World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02267005
Date of registration: 01/10/2014
Prospective Registration: Yes
Primary sponsor: The Hospital for Sick Children
Public title: The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Scientific title: The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis
Date of first enrolment: March 2015
Target sample size: 13
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02267005
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Supportive Care. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Canada
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Ages 7 to 18 years

- Diagnosis of probable JDM (onset <16 years) according to Bohan and Peter criteria

- Subjects on a stable course of medication (unlikely to change over study treatment
period as determined by the treating physician)

- Minimum height of 132.5cm

Exclusion Criteria:

- Subjects newly diagnosed with JDM within the previous 6 months

- Subjects unable to cooperate with study procedures, or too weak to participate in the
exercise testing

- Subjects with impaired kidney function as determined from baseline visit screening lab
values

- Subjects who are currently pregnant or planning to become pregnant within the study
period

- Subjects who are shorter than 132.5cm



Age minimum: 7 Years
Age maximum: 18 Years
Gender: All
Health Condition(s) or Problem(s) studied
Juvenile Dermatomyositis
Intervention(s)
Dietary Supplement: Glucose Tablet
Dietary Supplement: Creapure
Primary Outcome(s)
Muscle function [Time Frame: 6 months]
Secondary Outcome(s)
Quality of life [Time Frame: 6 months]
Muscle Strength [Time Frame: 6 months]
Adherence [Time Frame: 6 months]
Muscle metabolism [Time Frame: 6 months]
Disease Activity [Time Frame: 6 months]
Fatigue [Time Frame: 6 months]
Secondary ID(s)
1000041466
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history